This web edition of STAT’s AI Prognosis newsletter presents a preview of a longer, subscriber-only story titled “The secret AI-startup project I’ve been working on the last six months.” The article is dated Aug. 12, 2026, and the visible content on the public page is limited: STAT indicates the substantive reporting and analysis are exclusive to STAT+ subscribers. The page instructs readers to log in or subscribe to unlock the rest of the article and associated in-depth material.
The public portion frames the piece as part of the AI Prognosis series and highlights that the reporting concerns a secret project related to an AI startup. However, the source does not include the main investigative content, evidence, or conclusions — those elements are behind the STAT+ paywall and are not reported in the accessible page content.
The article is written by Brittany Trang, Ph.D., who is identified as a Health Tech reporter for STAT. The page supplies the author’s email address (brittany.trang@statnews.com) and notes that she covers AI in health and medicine with attention to practical effectiveness and equity: “Does it actually work? Who benefits, or might be harmed?” The author’s social handles and links are listed for Threads, Mastodon, Bluesky, and X, and a Signal contact (btrang.01) is provided for encrypted tips.
STAT also includes a secondary contact for the newsletter (aiprognosis@statnews.com) and invites readers to send responses or tips about the piece’s central questions — namely whether observed issues reflect normal growing pains for a company or indicate larger problems.
The page prominently identifies the story as exclusive to STAT+ subscribers. It displays subscription options and pricing visible on the public page, including monthly and annual plans and group pricing tiers. The site provides links for subscribing and logging in, and explicitly states that unlocking the rest of the story requires a STAT+ account.
Details shown in the preview include the STAT+ branding and calls to action to subscribe for full access, as well as navigation links to manage alerts, share the article, and sign up for the AI Prognosis newsletter. Beyond these subscription mechanics and promotional material, the substantive investigative content is not present in the source provided.
In the visible copy the author asks readers to weigh in on the interpretation of the reporting once they read the full piece, specifically whether the described matters are routine corporate growing pains or something more significant. Readers are encouraged to reply to the email associated with the newsletter or to contact the author directly via the provided email address or Signal handle. The newsletter contact address (aiprognosis@statnews.com) is supplied to collect tips and potential leads for further investigation.
The public page situates the item within STAT’s broader coverage of health technology, artificial intelligence, biotech, and related fields. It lists topic tags including artificial intelligence and health tech and links to other AI Prognosis installments. The site also displays a selection of recent and popular STAT+ stories and reporting in related categories (Biotech, Pharma, Public Health, Science), indicating editorial context for readers who may wish to explore related reporting.
The preview includes imagery and site navigation elements that connect the piece to STAT’s regular newsletter offerings and business model for premium journalism.
The source document made only the article preview available. Specifics about the alleged “secret AI-startup project” — such as the startup’s name, the nature of the project, methodologies, findings, participant quotes, documents, timelines, investor or regulatory context, or any investigative evidence — are not reported in the accessible content. The author’s substantive reporting and analysis are explicitly restricted to STAT+ subscribers, and the public page directs readers to subscribe for the full story.
Because the paywalled portion is not present in the source provided, this rewrite does not and cannot report facts that appear only in the subscriber-only article. Any further detail about the project’s claims, evidence, or implications was not reported in the available content and therefore is not summarized here.